These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 8661958

  • 1. Skeletal effects of calcitonin treatment and withdrawal in ovariectomized rats.
    Shen Y, Li M, Wronski TJ.
    Calcif Tissue Int; 1996 Apr; 58(4):263-7. PubMed ID: 8661958
    [Abstract] [Full Text] [Related]

  • 2. Calcitonin provides complete protection against cancellous bone loss in the femoral neck of ovariectomized rats.
    Shen Y, Li M, Wronski TJ.
    Calcif Tissue Int; 1997 May; 60(5):457-61. PubMed ID: 9115164
    [Abstract] [Full Text] [Related]

  • 3. Skeletal effects of calcitonin in ovariectomized rats.
    Wronski TJ, Yen CF, Burton KW, Mehta RC, Newman PS, Soltis EE, DeLuca PP.
    Endocrinology; 1991 Oct; 129(4):2246-50. PubMed ID: 1915104
    [Abstract] [Full Text] [Related]

  • 4. A comparison of the skeletal effects of intermittent and continuous administration of calcitonin in ovariectomized rats.
    Li M, Shen Y, Burton KW, DeLuca PP, Mehta RC, Baumann BD, Wronski TJ.
    Bone; 1996 Apr; 18(4):375-80. PubMed ID: 8726397
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats.
    Liang H, Pun S, Wronski TJ.
    Endocrinology; 1999 Dec; 140(12):5780-8. PubMed ID: 10579344
    [Abstract] [Full Text] [Related]

  • 7. Prophylactic effects of 1,24,25-trihydroxyvitamin D3 on ovariectomy-induced cancellous bone loss in the rat.
    Erben RG, Bante U, Birner H, Stangassinger M.
    Calcif Tissue Int; 1997 May; 60(5):434-40. PubMed ID: 9115161
    [Abstract] [Full Text] [Related]

  • 8. Comparative study of skeletal response to estrogen depletion at red and yellow marrow sites in rats.
    Li M, Shen Y, Qi H, Wronski TJ.
    Anat Rec; 1996 Jul; 245(3):472-80. PubMed ID: 8800405
    [Abstract] [Full Text] [Related]

  • 9. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ, Ratkus AM, Thomsen JS, Vulcan Q, Mosekilde L.
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [Abstract] [Full Text] [Related]

  • 10. Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats.
    Iwamoto J, Seki A, Takeda T, Sato Y, Yamada H, Yeh JK.
    Exp Anim; 2006 Jul; 55(4):357-67. PubMed ID: 16880683
    [Abstract] [Full Text] [Related]

  • 11. Time course of femoral neck osteopenia in ovariectomized rats.
    Li M, Shen Y, Wronski TJ.
    Bone; 1997 Jan; 20(1):55-61. PubMed ID: 8988348
    [Abstract] [Full Text] [Related]

  • 12. A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats.
    Qi H, Li M, Wronski TJ.
    J Bone Miner Res; 1995 Jun; 10(6):948-55. PubMed ID: 7572319
    [Abstract] [Full Text] [Related]

  • 13. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats.
    Wronski TJ, Yen CF, Qi H, Dann LM.
    Endocrinology; 1993 Feb; 132(2):823-31. PubMed ID: 8425497
    [Abstract] [Full Text] [Related]

  • 14. Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats.
    Wronski TJ, Cintrón M, Doherty AL, Dann LM.
    Endocrinology; 1988 Aug; 123(2):681-6. PubMed ID: 3396505
    [Abstract] [Full Text] [Related]

  • 15. Skeletal effects of parathyroid hormone (1-34) in ovariectomized rats with or without concurrent administration of salmon calcitonin.
    DeLuca PP, Dani BA.
    AAPS PharmSci; 2001 Aug; 3(4):E27. PubMed ID: 12049490
    [Abstract] [Full Text] [Related]

  • 16. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ, Simmons HA, Pirie CM, Crawford DT, Thompson DD.
    Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
    [Abstract] [Full Text] [Related]

  • 17. Time course of vertebral osteopenia in ovariectomized rats.
    Wronski TJ, Dann LM, Horner SL.
    Bone; 1989 Jun; 10(4):295-301. PubMed ID: 2803866
    [Abstract] [Full Text] [Related]

  • 18. Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomized rats.
    Wronski TJ, Dann LM, Scott KS, Crooke LR.
    Endocrinology; 1989 Aug; 125(2):810-6. PubMed ID: 2502377
    [Abstract] [Full Text] [Related]

  • 19. Alfacalcidol restores cancellous bone in ovariectomized rats.
    Li M, Healy DR, Simmons HA, Ke HZ, Thompson DD.
    J Musculoskelet Neuronal Interact; 2003 Mar; 3(1):39-46. PubMed ID: 15758364
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.